TY - JOUR
T1 - Longitudinal changes in serum 25-hydroxyvitamin D in the Dallas Heart Study
AU - Mirfakhraee, Sasan
AU - Ayers, Colby R.
AU - Mcguire, Darren K.
AU - Maalouf, Naim M.
N1 - Funding Information:
Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001105.
Publisher Copyright:
© 2017 John Wiley & Sons Ltd
PY - 2017/9
Y1 - 2017/9
N2 - Context: While the prevalence of vitamin D deficiency is well described in various populations, limited data are available regarding longitudinal variation in serum 25-hydroxyvitamin D concentrations. Objectives: To evaluate the temporal trends in serum 25(OH)D, prevalence of vitamin D deficiency and factors influencing these trends. Participants, Design and Setting:: Adults enrolled in the Dallas Heart Study, a longitudinal, probability-based, multiethnic, population study in Dallas, Texas, USA. Main Outcome Measures: Prevalence of vitamin D deficiency and predictors of change in serum 25(OH)D. Results: A total of 2045 participants had serum 25(OH)D measured on two occasions (2000-2002 and 2007-2009) at a median interval of 7 years. Serum 25(OH)D decreased (42.7-39.4 nmol/L, P<.001) and the prevalence of vitamin D deficiency [25(OH)D <50 nmol/L] increased significantly (60.6%-66.4%, P<.0001) despite vitamin D supplementation increasing over the interval (7.2%-23.0%; P<.0001). In a multivariable model adjusting for sex, race, BMI, age, season of blood draw, smoking and exercise, a greater decline in serum 25(OH)D was noted in men compared with women (−8.0 vs −3.5 nmol/L, P<.0001), in participants of Hispanic ethnicity vs White and Black ethnicity (P<.0001), in nonobese vs obese participants (−7.2 vs −4.0 nmol/L, P=.005) and in nonusers vs users of vitamin D supplements (−5.7 vs −1.7 nmol/L, P=.032). Conclusions: Despite increased vitamin D supplementation, serum 25(OH)D decreased in an ethnically diverse cohort of Dallas County residents between 2000-2002 and 2007-2009. Features most predictive of a decline in serum 25(OH)D include male sex, Hispanic ethnicity and weight gain.
AB - Context: While the prevalence of vitamin D deficiency is well described in various populations, limited data are available regarding longitudinal variation in serum 25-hydroxyvitamin D concentrations. Objectives: To evaluate the temporal trends in serum 25(OH)D, prevalence of vitamin D deficiency and factors influencing these trends. Participants, Design and Setting:: Adults enrolled in the Dallas Heart Study, a longitudinal, probability-based, multiethnic, population study in Dallas, Texas, USA. Main Outcome Measures: Prevalence of vitamin D deficiency and predictors of change in serum 25(OH)D. Results: A total of 2045 participants had serum 25(OH)D measured on two occasions (2000-2002 and 2007-2009) at a median interval of 7 years. Serum 25(OH)D decreased (42.7-39.4 nmol/L, P<.001) and the prevalence of vitamin D deficiency [25(OH)D <50 nmol/L] increased significantly (60.6%-66.4%, P<.0001) despite vitamin D supplementation increasing over the interval (7.2%-23.0%; P<.0001). In a multivariable model adjusting for sex, race, BMI, age, season of blood draw, smoking and exercise, a greater decline in serum 25(OH)D was noted in men compared with women (−8.0 vs −3.5 nmol/L, P<.0001), in participants of Hispanic ethnicity vs White and Black ethnicity (P<.0001), in nonobese vs obese participants (−7.2 vs −4.0 nmol/L, P=.005) and in nonusers vs users of vitamin D supplements (−5.7 vs −1.7 nmol/L, P=.032). Conclusions: Despite increased vitamin D supplementation, serum 25(OH)D decreased in an ethnically diverse cohort of Dallas County residents between 2000-2002 and 2007-2009. Features most predictive of a decline in serum 25(OH)D include male sex, Hispanic ethnicity and weight gain.
KW - 25-hydroxyvitamin D
KW - longitudinal
KW - vitamin D
KW - vitamin D deficiency
UR - http://www.scopus.com/inward/record.url?scp=85020726897&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020726897&partnerID=8YFLogxK
U2 - 10.1111/cen.13374
DO - 10.1111/cen.13374
M3 - Article
C2 - 28502105
AN - SCOPUS:85020726897
SN - 0300-0664
VL - 87
SP - 242
EP - 248
JO - Clinical Endocrinology
JF - Clinical Endocrinology
IS - 3
ER -